EPIPHYSIOLYSIS

This adverse event was reported 249 times

EPIPHYSIOLYSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SOMAPACITAN-BECO 2 0.0110
1 BRINCIDOFOVIR 1 0.0072
2 MECASERMIN 4 0.0049
3 SOMATROGON-GHLA 5 0.0040
4 ERDAFITINIB 3 0.0024
5 DESMOPRESSIN ACETATE 6 0.0016
6 TRIPTORELIN PAMOATE 4 0.0015
7 SOMATROPIN 90 0.0012
8 TRIPTORELIN 4 0.0012
9 PEMIGATINIB 1 0.0012
See all drugs enriched for association with EPIPHYSIOLYSIS

EPIPHYSIOLYSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Recombinant Human Growth Hormone [EPC] 62 0.0028
1 Thyroid Hormone Synthesis Inhibitor [EPC] 4 0.0004
2 Sulfone [EPC] 1 0.0001
3 Aromatase Inhibitor [EPC] 10 0.0001
4 Androgen [EPC] 2 0.0001
5 Leukotriene Receptor Antagonist [EPC] 2 0.0001
6 Topoisomerase Inhibitor [EPC] 5 0.0001
7 Alkylating Drug [EPC] 9 0.0000
8 Mood Stabilizer [EPC] 8 0.0000
9 Anti-epileptic Agent [EPC] 8 0.0000
See all drug classes enriched for association with EPIPHYSIOLYSIS